Lupus Efficacy Studies

Preclinical Drug Development

$0.28 - $3.00

Select Options

Preclinical Lupus Models and Studies

$0.49 - $7.00

Select Options

A New MHC Class I & II Deficient Platform Humanized With PBMC Has Delayed Xenogeneic GvHD

$0.96 - $9.00

Select Options

GvHD Studies Graft vs Host Disease

$0.49 - $7.00

Select Options

In Vivo Safety and Efficacy Platform for Immunotherapies

$0.49 - $7.00

Select Options

Comprehensive Immunodeficient Suite

$1.52 - $6.00

Select Options

In Vivo Evaluation Of Bispecific T-Cell Engager Efficacy & Safety

$0.49 - $7.00

Select Options

Achieving Relevant Preclinical Characterization of CAR T Cell Therapies

$0.84 - $9.00

Select Options